Journal
SUPPORTIVE CARE IN CANCER
Volume 21, Issue 1, Pages 303-308Publisher
SPRINGER
DOI: 10.1007/s00520-012-1592-7
Keywords
Mucositis; MASCC/ISOO; Methodology
Funding
- Helsinn Healthcare S.A., Switzerland
- BioAlliance Pharma, France
Ask authors/readers for more resources
Members of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) recently completed the process of updating the MASCC/ISOO Clinical Practice Guidelines for the prevention and treatment of mucositis. These guidelines, originally published in 2004, and last updated in 2007, provide clinicians with objective, evidence-based recommendations for the management of mucositis secondary to cancer therapy. This brief paper describes the methodology used to conduct the most recent systematic review in 2011, and develop new guidelines, providing the basis for the update. The overriding aims of the process were to assess evidence of effectiveness of interventions for the prevention and treatment of mucositis and to produce clinical practice guidelines for the management of mucositis using best available evidence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available